METHOTREXATE IN PSORIASIS - REVISED GUIDELINES

被引:293
作者
ROENIGK, HH
AUERBACH, R
MAIBACH, HI
WEINSTEIN, GD
机构
[1] UNIV CALIF SAN FRANCISCO, MED CTR, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF IRVINE, COLL MED, DEPT DERMATOL, IRVINE, CA 92717 USA
关键词
D O I
10.1016/S0190-9622(88)80237-8
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:145 / 156
页数:12
相关论文
共 100 条
  • [1] AHERNE GW, 1981, CANCER TREAT REP, V65, P55
  • [2] PROLONGATION AND ENHANCEMENT OF SERUM METHOTREXATE CONCENTRATIONS BY PROBENECID
    AHERNE, GW
    PIALL, E
    MARKS, V
    MOULD, G
    WHITE, WF
    [J]. BRITISH MEDICAL JOURNAL, 1978, 1 (6120) : 1097 - 1099
  • [3] LEUKOCYTE MIGRATION-INHIBITION IN METHOTREXATE-INDUCED PNEUMONITIS - EVIDENCE FOR AN IMMUNOLOGICAL CELL-MEDIATED MECHANISM
    AKOUN, GM
    GAUTHIERRAHMAN, S
    MAYAUD, CM
    TOUBOUL, JL
    DENIS, MF
    [J]. CHEST, 1987, 91 (01) : 96 - 99
  • [4] CRYPTOCOCCOSIS ASSOCIATED WITH LOW-DOSE METHOTREXATE FOR ARTHRITIS
    ALTZSMITH, M
    KENDALL, LG
    STAMM, AM
    [J]. AMERICAN JOURNAL OF MEDICINE, 1987, 83 (01) : 179 - 181
  • [5] COMPLICATIONS IN METHOTREXATE TREATMENT OF PSORIASIS WITH PARTICULAR REFERENCE TO LIVER FIBROSIS
    ASHTON, RE
    MILLWARDSADLER, GH
    WHITE, JE
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 79 (04) : 229 - 232
  • [6] BAGSHAWE KD, 1976, CANCER, V38, P1373, DOI 10.1002/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO
  • [7] 2-E
  • [8] IS METHOTREXATE THERAPY FOR PSORIASIS CARCINOGENIC - MODIFIED RETROSPECTIVE PROSPECTIVE ANALYSIS
    BAILIN, PL
    TINDALL, JP
    ROENIGK, HH
    HOGAN, MD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 232 (04): : 359 - 362
  • [9] TOXIC HEPATITIS DUE TO COMBINATION THERAPY WITH METHOTREXATE AND ETRETINATE IN PSORIASIS
    BECK, HI
    FOGED, EK
    [J]. DERMATOLOGICA, 1983, 167 (02): : 94 - 96
  • [10] CLINICAL-PHARMACOLOGY OF METHOTREXATE
    BERTINO, JR
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (04): : 401 - 411